Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treating Helicobacter pylori effectively while minimizing misuse of antibiotics.

Literature DB >> 28388387

Treating Helicobacter pylori effectively while minimizing misuse of antibiotics.

Akiko Shiotani¹, Hong Lu^2,3,4, Maria Pina Dore⁵, David Y Graham⁶.

Abstract

Experts now recommend that all Helicobacter pylori infections be eradicated unless there are compelling reasons not to. As with other infectious diseases, effective therapy should be based on susceptibility.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2017 PMID： 28388387 PMCID： PMC6905081 DOI： 10.3949/ccjm.84a.14110

Source DB: PubMed Journal: Cleve Clin J Med ISSN： 0891-1150 Impact factor: 2.321

40 in total

Review 1. Review article: the control of gastric acid and Helicobacter pylori eradication.

Authors: G Sachs; J M Shin; K Munson; O Vagin; N Lambrecht; D R Scott; D L Weeks; K Melchers
Journal: Aliment Pharmacol Ther Date: 2000-11 Impact factor: 8.171

Review 2. Helicobacter pylori treatment in the era of increasing antibiotic resistance.

Authors: David Y Graham; Lori Fischbach
Journal: Gut Date: 2010-06-04 Impact factor: 23.059

Review 3. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.

Authors: Carlo A Fallone; Naoki Chiba; Sander Veldhuyzen van Zanten; Lori Fischbach; Javier P Gisbert; Richard H Hunt; Nicola L Jones; Craig Render; Grigorios I Leontiadis; Paul Moayyedi; John K Marshall
Journal: Gastroenterology Date: 2016-04-19 Impact factor: 22.682

4. Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection.

Authors: A G McNicholl; P M Linares; O P Nyssen; X Calvet; J P Gisbert
Journal: Aliment Pharmacol Ther Date: 2012-07-15 Impact factor: 8.171

Review 5. Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis.

Authors: Min-Min Zhang; Wei Qian; Ying-Yi Qin; Jia He; Yu-Hao Zhou
Journal: World J Gastroenterol Date: 2015-04-14 Impact factor: 5.742

Review 6. Epidemiology of Helicobacter pylori infection.

Authors: Mārcis Leja; Anthony Axon; Hermann Brenner
Journal: Helicobacter Date: 2016-09 Impact factor: 5.753

Review 7. Antibiotic resistance in Helicobacter pylori: implications for therapy.

Authors: D Y Graham
Journal: Gastroenterology Date: 1998-11 Impact factor: 22.682

8. Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy.

Authors: Qi Chen; Wei Zhang; Qingyan Fu; Xiao Liang; Wenzhong Liu; Shudong Xiao; Hong Lu
Journal: Am J Gastroenterol Date: 2016-09-27 Impact factor: 10.864

9. Furazolidone in Helicobacter pylori therapy: misunderstood and often unfairly maligned drug told in a story of French bread.

Authors: David Y Graham; Hong Lu
Journal: Saudi J Gastroenterol Date: 2012 Jan-Feb Impact factor: 2.485

10. Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study.

Authors: Kazunari Murakami; Yuuichi Sakurai; Madoka Shiino; Nobuo Funao; Akira Nishimura; Masahiro Asaka
Journal: Gut Date: 2016-03-02 Impact factor: 23.059

18 in total

1. It is time to rethink H. pylori therapy.

Authors: Bich N Dang; David Y Graham
Journal: J Gastrointestin Liver Dis Date: 2017-06 Impact factor: 2.008

2. Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI.

Authors: David Y Graham; Hong Lu; Maria Pina Dore
Journal: Helicobacter Date: 2018-11-15 Impact factor: 5.753

3. Helicobacter pylori infection and antibiotic resistance: a WHO high priority?

Authors: Bich N Dang; David Y Graham
Journal: Nat Rev Gastroenterol Hepatol Date: 2017-05-03 Impact factor: 46.802

4. Syzygium aromaticum L.: Traditional herbal medicine against cagA and vacA toxin genes-producing drug resistant Helicobacter pylori.

Authors: Wagih A El-Shouny; Sameh S Ali; Hegazy M Hegazy; Manar K Abd Elnabi; Asmaa Ali; Jianzhong Sun
Journal: J Tradit Complement Med Date: 2019-05-15

5. Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States.

Authors: Hashem B El-Serag; John Y Kao; Fasiha Kanwal; Mark Gilger; Frank LoVecchio; Steven F Moss; Sheila E Crowe; Adam Elfant; Thomas Haas; Ronald J Hapke; David Y Graham
Journal: Clin Gastroenterol Hepatol Date: 2018-03-17 Impact factor: 11.382

Review 6. Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies.

Authors: David Y Graham; Maria Pina Dore; Hong Lu
Journal: Expert Rev Anti Infect Ther Date: 2018-08-23 Impact factor: 5.091

Review 7. Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications.

Authors: Evariste Tshibangu-Kabamba; Yoshio Yamaoka
Journal: Nat Rev Gastroenterol Hepatol Date: 2021-05-17 Impact factor: 46.802

8. Efficacy of Helicobacter pylori eradication regimens in Rwanda: a randomized controlled trial.

Authors: Jean Damascene Kabakambira; Celestin Hategeka; Cameron Page; Cyprien Ntirenganya; Vincent Dusabejambo; Jules Ndoli; Francois Ngabonziza; DeVon Hale; Claude Bayingana; Tim Walker
Journal: BMC Gastroenterol Date: 2018-08-30 Impact factor: 3.067

9. Susceptibility-guided therapy for Helicobacter pylori infection treatment failures.

Authors: Lou Yu; Laisheng Luo; Xiaohua Long; Xiao Liang; Yingjie Ji; Qi Chen; Yanyan Song; Xiaobo Li; David Y Graham; Hong Lu
Journal: Therap Adv Gastroenterol Date: 2019-09-09 Impact factor: 4.409

Review 10. What Would the Screen-and-Treat Strategy for Helicobacter pylori Mean in Terms of Antibiotic Consumption?

Authors: Mārcis Leja; Uga Dumpis
Journal: Dig Dis Sci Date: 2019-10-28 Impact factor: 3.199